Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

[摘要]：The identification of an agent that is selectively activated by a cytochrome P450 (CYP) has the potential for tissue specific dose intensification as a means of significantly improving its therapeutic value. Towards this goal, we disclose evidence for the pathway of activation of a duocarmycin analogue, ICT2700, which targets CYP1A1 for biological activity.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内